Your browser doesn't support javascript.
loading
Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
Fukuta, Y; Fukuda, Y; Higashino, R; Yoshida, K; Ogishima, M; Tamaki, H; Takei, M.
Affiliation
  • Fukuta Y; Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan.
J Pharmacol Exp Ther ; 290(3): 1013-8, 1999 Sep.
Article in En | MEDLINE | ID: mdl-10454472
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Receptors, Adrenergic, alpha-1 / Adrenergic alpha-Antagonists / Enzyme Inhibitors / 5-alpha Reductase Inhibitors / Indoles Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Receptors, Adrenergic, alpha-1 / Adrenergic alpha-Antagonists / Enzyme Inhibitors / 5-alpha Reductase Inhibitors / Indoles Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United States